Xiao Jie Liu
Director/Board Member bij YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.
Profiel
Xiao Jie Liu is currently the Board Secretary, Director & Deputy General Manager at Yantai Dongcheng Biochemicals Co., Ltd.
since 2022.
He is also currently a Director at MITRO Biotech Co., Ltd.
since 2020.
Previously, he worked as an Accounting Manager at Yantai Dongcheng Biochemicals Co., Ltd.
Mr. Liu completed his undergraduate degree at Shandong University of Finance & Economics.
Actieve functies van Xiao Jie Liu
| Bedrijven | Functie | Begin |
|---|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Director/Board Member | 19-05-2022 |
Mitro Biotech Co., Ltd.
 Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China. | Director/Board Member | 25-07-2020 |
Eerdere bekende functies van Xiao Jie Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Public Communications Contact | - |
Opleiding van Xiao Jie Liu
| Shandong University of Finance & Economics | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Mitro Biotech Co., Ltd.
Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China. | Commercial Services |
